HuGE Literature Finder
Records
1
-
14
| A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer. Frontiers in medicine 2022 9 808378. Peng Jie, Xiao Lushan, Zou Dan, Han Lij |
| Mutational Landscape and Outcomes of Conjunctival Melanoma in 101 Patients. Ophthalmology 2022 1 129 (6): 679-693. Lally Sara E, Milman Tatyana, Orloff Marlana, Dalvin Lauren A, Eberhart Charles G, Heaphy Christopher M, Rodriguez Fausto J, Lin Chun-Chieh, Dockery Philip W, Shields Jerry A, Shields Carol |
| The cuproptosis-related signature associated with the tumor environment and prognosis of patients with glioma. Frontiers in immunology 2022 13 998236. Wang Weichen, Lu Zhichao, Wang Maoyu, Liu Zongheng, Wu Bing, Yang Chengkai, Huan He, Gong Peip |
| Comprehensive characterization of distinct genetic alterations in metastatic breast cancer across various metastatic sites. NPJ breast cancer 2021 Jul 7 (1): 93. Cha Soojin, Lee Esak, Won Hong-H |
| Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis. Frontiers in endocrinology 2021 12 691557. Wang Fei, Xu Xiaowu, Ye Zeng, Qin Yi, Yu Xianjun, Ji Shunro |
| ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors. Human pathology 2018 Aug . Chou Angela, Itchins Malinda, de Reuver Philip R, Arena Jennifer, Clarkson Adele, Sheen Amy, Sioson Loretta, Cheung Veronica, Perren Aurel, Nahm Christopher, Mittal Anubhav, Samra Jaswinder S, Pajic Marina, Gill Anthony |
| Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine Tumors and Reduced Patient Survival Times. Gastroenterology 2018 2 154 (8): 2060-2063.e8. Roy Somak, LaFramboise William A, Liu Ta-Chiang, Cao Dengfeng, Luvison Alyssa, Miller Caitlyn, Lyons Maureen A, O'Sullivan Roderick J, Zureikat Amer H, Hogg Melissa E, Tsung Allan, Lee Kenneth K, Bahary Nathan, Brand Randall E, Chennat Jennifer S, Fasanella Kenneth E, McGrath Kevin, Nikiforova Marina N, Papachristou Georgios I, Slivka Adam, Zeh Herbert J, Singhi Aatur |
| Clinicopathological analysis of ATRX, DAXX and NOTCH receptor expression in angiosarcomas. Histopathology 2017 Aug . Panse Gauri, Chrisinger John Sa, Leung Cheuk H, Ingram Davis R, Khan Samia, Wani Khalida, Lin Heather, Lazar Alexander J, Wang Wei-Li |
| Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures. The oncologist 2017 9 22 (12): 1478-1490. Johnson Adrienne, Severson Eric, Gay Laurie, Vergilio Jo-Anne, Elvin Julia, Suh James, Daniel Sugganth, Covert Mandy, Frampton Garrett M, Hsu Sigmund, Lesser Glenn J, Stogner-Underwood Kimberly, Mott Ryan T, Rush Sarah Z, Stanke Jennifer J, Dahiya Sonika, Sun James, Reddy Prasanth, Chalmers Zachary R, Erlich Rachel, Chudnovsky Yakov, Fabrizio David, Schrock Alexa B, Ali Siraj, Miller Vincent, Stephens Philip J, Ross Jeffrey, Crawford John R, Ramkissoon Shakti |
| Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12. PLoS genetics 2016 Feb 12 (2): e1005850. Mäkinen Netta, Aavikko Mervi, Heikkinen Tuomas, Taipale Minna, Taipale Jussi, Koivisto-Korander Riitta, Bützow Ralf, Vahteristo P |
| TERT promoter mutations are a rare event in gastrointestinal stromal tumors. SpringerPlus 2015 4 836. Akaike Keisuke, Toda-Ishii Midori, Suehara Yoshiyuki, Mukaihara Kenta, Kubota Daisuke, Mitani Keiko, Takagi Tatsuya, Kaneko Kazuo, Yao Takashi, Saito Tsuyos |
| Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012 Feb 482 (7384): 226-31. Schwartzentruber Jeremy, Korshunov Andrey, Liu Xiao-Yang, Jones David T W, Pfaff Elke, Jacob Karine, Sturm Dominik, Fontebasso Adam M, Quang Dong-Anh Khuong, Tönjes Martje, Hovestadt Volker, Albrecht Steffen, Kool Marcel, Nantel Andre, Konermann Carolin, Lindroth Anders, Jäger Natalie, Rausch Tobias, Ryzhova Marina, Korbel Jan O, Hielscher Thomas, Hauser Peter, Garami Miklos, Klekner Almos, Bognar Laszlo, Ebinger Martin, Schuhmann Martin U, Scheurlen Wolfram, Pekrun Arnulf, Frühwald Michael C, Roggendorf Wolfgang, Kramm Christoph, Dürken Matthias, Atkinson Jeffrey, Lepage Pierre, Montpetit Alexandre, Zakrzewska Magdalena, Zakrzewski Krzystof, Liberski Pawel P, Dong Zhifeng, Siegel Peter, Kulozik Andreas E, Zapatka Marc, Guha Abhijit, Malkin David, Felsberg Jörg, Reifenberger Guido, von Deimling Andreas, Ichimura Koichi, Collins V Peter, Witt Hendrik, Milde Till, Witt Olaf, Zhang Cindy, Castelo-Branco Pedro, Lichter Peter, Faury Damien, Tabori Uri, Plass Christoph, Majewski Jacek, Pfister Stefan M, Jabado Na |
| DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science (New York, N.Y.) 2011 1 331 (6021): 1199-203. Jiao Yuchen, Shi Chanjuan, Edil Barish H, de Wilde Roeland F, Klimstra David S, Maitra Anirban, Schulick Richard D, Tang Laura H, Wolfgang Christopher L, Choti Michael A, Velculescu Victor E, Diaz Luis A, Vogelstein Bert, Kinzler Kenneth W, Hruban Ralph H, Papadopoulos Nickol |
| Molecular profile of tumors with oligodendroglial morphology: Clinical relevance. Neurology India 0 66 (6): 1726-1731. Geevar Tulasi, Pai Rekha, Chacko Geeta, Malepathi Karthik, Patel Bimal, John Jacob, Chacko Ari G, Balakrishnan Rajesh, John Subashi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: